Healthcare traction Cupon's antimicrobial technology is embedded into linens and hard surfaces with EPA-treated article claims, supported by a hospital study (Sentara) showing reduced drug-resistant organisms like MRSA. This creates a compelling entry point to supply copper-infused patient gowns, sheets, towels, linens, and related textiles to hospitals and healthcare facilities, with infection prevention and materials procurement teams as primary buyers.

Versatile integration Cupron's copper technology can be integrated into films, fibers, polymeric solids, foams, coatings and aqueous systems, offering durability against UV, chemicals and heat. This enables cross-vertical sales opportunities across medical textiles, personal care, plastics, hygiene products and industrial coatings.

Regulatory credibility Cupon's claims from the EPA-backed treated articles provide credibility for buyers requiring regulatory-backed antimicrobial performance. The Cupron Sinerji product line expansion further broadens application readiness, supporting conversations with healthcare facilities, manufacturers and distributors seeking compliant antimicrobial solutions.

Growth momentum Recent financing of four million dollars in 2025 and historic growth milestones, including U.S. expansion and Cupron Sinerji launch, signal capacity to scale supply and pursue co-development or exclusive supply arrangements with manufacturers and healthcare distributors.

Sustainability focus Sustainable copper usage and durable antimicrobial performance align with ESG-driven procurement. The East Coast base and ongoing hospital testing create near-term regional opportunities with healthcare networks, textile producers, and plastics manufacturers seeking durable, environmentally-conscious antimicrobial solutions.